Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
Clinical trial NCT06167694 · RECRUITING
Trial details
- NCT number
- NCT06167694
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-06-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.